Genome Engineering Market Outlook | Growth Opportunities 2023

1
(No Transcript)
2
Market Overview
The global genome engineering market size was
valued at USD 5,105.20 million in 2022 and is
poised to grow at a significant CAGR of 14.2
during the forecast period 2023-29. The genome
engineering market research report also provides
opportunities for business owners to exploit
through the use of relevant approaches. The
studys prospects assist stakeholders and report
purchasers in properly planning their investments
and augmenting their profits. The report
provides a quantitative analysis of the market
segments, trends, estimations, and dynamics of
the genome engineering market analysis from 2023
to 2029 to identify the prevailing market
opportunities. In addition, the report discusses
the implications of COVID-19, including the
industry's initial response and strategies for
ensuring business continuity in the coming
years. View Detailed Report Description
3
Market Segments

• The genome engineering market has been fragmented
  based on
• By Delivery Mode Ex-vivo, In-vivo.
• By Technology CRISPR, ZFN, TALEN.
• By Application Animal/Plant Cell Editing.
• By End-use Pharmaceutical Biotechnology
  Companies, Academic Research Institutions,
  Others
• Request Sample Report

4
Key Players

• Some of the major key players in the genome
  engineering market are
• CRISPR Therapeutics,
• Thermo Fisher Scientific
• GenScript Corporation
• Sangamo Therapeutics, Inc
• Horizon Discovery Group
• Integrated DNA Technologies
• New England Biolabs
• OriGene Technologies
• Lonza Group
• Editas Medicine
• Request Sample Report

5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB
Colony, Hyderabad 500072 Email sales_at_precisionb
usinessinsights.com Toll-Free 1-866-598-1553